Drug class
Centrally acting skeletal-muscle relaxant; piperidine derivative
Mechanism of action
Acts on spinal reflex pathways and reduces reflex-mediated skeletal-muscle tone. Experimental work supports depression of spinal reflex activity and effects on voltage-gated sodium/calcium channels; a 2024 study also reported P2X7 antagonism, but the established clinical mechanism remains incompletely elucidated.
General use cases
- Improvement of myotonic conditions associated with neck-shoulder-arm syndrome, scapulohumeral periarthritis and low back pain
- Spastic paralysis associated with selected cerebrovascular, spinal and other neurological disorders in the cited Japanese product information; authorisation varies by country
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
